Adams Street Partners’s Icosavax, Inc. Common Stock ICVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-2,179,964
Closed -$16.9M 20
2023
Q3
$16.9M Sell
2,179,964
-900
-0% -$7.46K 5.9% 7
2023
Q2
$21.7M Sell
2,180,864
-39,817
-2% -$319K 5.66% 5
2023
Q1
$12.9M Sell
2,220,681
-254,918
-10% -$2.2M 4.02% 6
2022
Q4
$19.7M Sell
2,475,599
-916,793
-27% -$3.93M 6.56% 5
2022
Q3
$10.7M Hold
3,392,392
2.94% 5
2022
Q2
$19.4M Hold
3,392,392
5.06% 5
2022
Q1
$23.9M Sell
3,392,392
-3
-0% -$47 4.42% 6
2021
Q4
$73.7M Hold
3,392,395
11.25% 4
2021
Q3
$90.3M Buy
+3,392,395
New +$115M 11.6% 3

Other funds holding ICVX

Adams Street Partners's ICVX Position: Q4 2023 in Review

Adams Street Partners sold out of Icosavax, Inc. Common Stock (ICVX) in Q4 2023, closing a stake of 2,179,964 shares — an estimated $16.9M sold.

Adams Street Partners first reported a position in ICVX in Q3 2021 and held it in 9 quarters. The position peaked at $90.3M in Q3 2021. 93 funds tracked by Wall St. Rank hold ICVX as of Q4 2023.

  • Adams Street Partners reported no remaining Icosavax, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Adams Street Partners sold 2,179,964 Icosavax, Inc. Common Stock shares in Q4 2023, an estimated $16.9M.
  • Adams Street Partners first reported a position in Icosavax, Inc. Common Stock in Q3 2021 and held it in 9 quarters.
  • Adams Street Partners's Icosavax, Inc. Common Stock position peaked at $90.3M in Q3 2021.
  • 93 funds tracked by Wall St. Rank held Icosavax, Inc. Common Stock as of Q4 2023.

Based on Adams Street Partners's 13F filing for Q4 2023, filed 14 Feb 2024.